Login / Signup
Paul J Mather
ORCID
Publication Activity (10 Years)
Years Active: 2021-2021
Publications (10 Years): 1
Top Topics
Angiotensin Converting Enzyme
Acute Heart Failure
Ejection Fraction
Drug Administration
Top Venues
Therapeutic advances in cardiovascular disease
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Michael V Genuardi
,
Paul J Mather
The dawn of the four-drug era? SGLT2 inhibition in heart failure with reduced ejection fraction.
Therapeutic advances in cardiovascular disease
15 (2021)